With an increase in the number of patients with malignant tumors, managing various symptoms of terminal ill cancer patients has become essential. Malignant bowel obstruction (MBO) is a serious complication commonl
Patients with peritoneal metastases from appendix cancer are at high risk of malignant bowel obstruc...
The Authors report their experience in the palliative management of malignant colorectal obstruction...
There are not guidelines for surgical management of malignant bowel obstruction (MBO) caused by peri...
Octreotide in the management of intestinal obstruction in terminal cancer patients
Malignant bowel obstruction and intractable diarrhea in advanced cancer are common devastating syndr...
INTRODUCTION : Malignant bowel obstruction (MBO) is harrowing complication of gastrointestinal cance...
Objective: In patients with advanced cancer, malignant bowel obstruction (MBO) causes gastrointestin...
The use of symptomatic agents has greatly improved the medical treatment of advanced cancer patient...
In the case of malignant intestinal obstruction, surgery often carries important mortality and morbi...
BackgroundAlthough malignant bowel obstruction (MBO) often is a terminal event, systemic therapies a...
BACKGROUND: Malignant bowel obstruction is experienced by 15% of people with advanced cancer, preven...
Mr XY is a 75-year-old man with known recurrent rectosigmoid adenocarcinoma in the pelvis. He had an...
To provide evidence-based recommendations on the management of malignant bowel obstruction (MBO) for...
BackgroundMalignant bowel obstruction is experienced by 15% of people with advanced cancer, preventi...
Malignant bowel obstruction (MBO) is a major complication in women with advanced gynecologic cancers...
Patients with peritoneal metastases from appendix cancer are at high risk of malignant bowel obstruc...
The Authors report their experience in the palliative management of malignant colorectal obstruction...
There are not guidelines for surgical management of malignant bowel obstruction (MBO) caused by peri...
Octreotide in the management of intestinal obstruction in terminal cancer patients
Malignant bowel obstruction and intractable diarrhea in advanced cancer are common devastating syndr...
INTRODUCTION : Malignant bowel obstruction (MBO) is harrowing complication of gastrointestinal cance...
Objective: In patients with advanced cancer, malignant bowel obstruction (MBO) causes gastrointestin...
The use of symptomatic agents has greatly improved the medical treatment of advanced cancer patient...
In the case of malignant intestinal obstruction, surgery often carries important mortality and morbi...
BackgroundAlthough malignant bowel obstruction (MBO) often is a terminal event, systemic therapies a...
BACKGROUND: Malignant bowel obstruction is experienced by 15% of people with advanced cancer, preven...
Mr XY is a 75-year-old man with known recurrent rectosigmoid adenocarcinoma in the pelvis. He had an...
To provide evidence-based recommendations on the management of malignant bowel obstruction (MBO) for...
BackgroundMalignant bowel obstruction is experienced by 15% of people with advanced cancer, preventi...
Malignant bowel obstruction (MBO) is a major complication in women with advanced gynecologic cancers...
Patients with peritoneal metastases from appendix cancer are at high risk of malignant bowel obstruc...
The Authors report their experience in the palliative management of malignant colorectal obstruction...
There are not guidelines for surgical management of malignant bowel obstruction (MBO) caused by peri...